TrialNature medicine2023

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials.

Gil Yosipovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.